Information about Canadian-Internet-Drugs.com
List of countries where we can ship Cyclophosphamide:
Latest news releases on Cyclophosphamide:
(sye-kloe-FAHS-fah-mide) Trade Names: Cytoxan®, Neosar® Cyclophosphamide is the generic name for the trade name drug Cytoxan or Neosar. In some cases, health care professionals may use the trade name Cytoxan or Neosar when referring to the generic drug name cyclophosphamide.
Medscape - Indication-specific dosing for Cytoxan (cyclophosphamide), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information.
Physician reviewed cyclophosphamide (oral and injection) (oral and injection) patient information - includes cyclophosphamide (oral and injection) description, dosage and directions.
Cytoxan (cyclophosphamide) is a cancer (chemotherapy) medication used to treat several types of cancer. Cytoxan is also used to treat certain cases of nephrotic syndrome (kidney disease) in children.
Cyclophosphamide is often used for three - six months to treat a condition and put it into remission. Afterwards, a medication that may be less potent with fewer side effects is used to maintain the disease in remission.
FULL PRESCRIBING INFORMATION . 1. INDICATIONS AND USAGE 1.1 Malignant Diseases . Cyclophosphamide is indicated for the treatment of: malignant lymphomas (Stages III and IV of the Ann Arbor staging system), Hodgkin’s disease,
Cyclophosphamide injectable solution is a prescription medication used to treat many types of cancer. It's only available as a generic drug. A healthcare provider will give you this medication through an intravenous (IV) infusion. You won't take this drug at home. Learn about side effects, warnings, and more.
Cyclophosphamide is used to treat various types of cancer. It is a chemotherapy drug that works by slowing or stopping cell growth. Cyclophosphamide also works by decreasing your immune system's response to various diseases.
1. Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
1. Arthritis Rheum. 2002 Aug;46(8):2121-31. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.